NEW YORK, April 12 - Zyomyx and Axon Instruments have agreed to jointly develop scanning instrumentation for acquiring and analyzing data from Zyomyx's protein biochips, the companies said Thursday.

Zyomyx, which has said it plans to release a beta version of its chip later this year, will work with Axon to build several generations of scanning products and evaluate fluorescence and non-fluorescence platforms. The companies did not disclose financial details.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.